Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Erlotinib | 0.0033113 | uM | 8 | 156.25 | 23.19 | 349.00 | 390.75 | 0.8932 | 0.9453 |
MCF 10A | Erlotinib | 0.31623 | uM | 7 | 625.00 | 98.92 | 2444.00 | 7246.75 | 0.3373 | 0.6782 |
MCF 10A | Erlotinib | 10 | uM | 9 | 1250.00 | 369.45 | 472.00 | 6960.50 | 0.0678 | 0.0595 |
MCF 10A | Erlotinib | 19.9526 | uM | 7 | 625.00 | 98.92 | 376.00 | 7246.75 | 0.0519 | 0.2405 |
MCF 10A | Erlotinib | 0.031623 | uM | 9 | 1250.00 | 369.45 | 7398.00 | 6960.50 | 1.0629 | 1.0290 |
MCF 10A | Erlotinib | 3.1623 | uM | 9 | 1250.00 | 369.45 | 567.00 | 6960.50 | 0.0815 | 0.1064 |
MCF 10A | Erlotinib | 0.31623 | uM | 9 | 1250.00 | 369.45 | 4829.00 | 6960.50 | 0.6938 | 0.8346 |
SK-BR-3 | Erlotinib | 0.1 | uM | 7 | 1250.00 | 859.67 | 2095.00 | 2002.25 | 1.0463 | 1.0756 |
MCF 10A | Erlotinib | 1 | uM | 9 | 1250.00 | 369.45 | 410.00 | 6960.50 | 0.0589 | 0.0249 |
SK-BR-3 | Erlotinib | 0.1 | uM | 8 | 1250.00 | 894.42 | 2227.00 | 2319.50 | 0.9601 | 0.9417 |
MCF 10A | Erlotinib | 0.1 | uM | 8 | 312.50 | 114.17 | 1415.00 | 1487.00 | 0.9516 | 0.9734 |
SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 830.55 | 1269.00 | 1981.25 | 0.6405 | 0.4021 |
SK-BR-3 | Erlotinib | 0.0033113 | uM | 8 | 1250.00 | 894.42 | 2346.00 | 2319.50 | 1.0114 | 1.0166 |
MCF 10A | Erlotinib | 0.01 | uM | 9 | 1250.00 | 369.45 | 7185.00 | 6960.50 | 1.0323 | 1.0150 |
SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 1250.00 | 894.42 | 2141.00 | 2319.50 | 0.9230 | 0.8868 |
MCF 10A | Erlotinib | 0.0033113 | uM | 9 | 625.00 | 186.95 | 3263.00 | 2801.00 | 1.1649 | 1.0797 |
MCF 10A | Erlotinib | 0.031623 | uM | 7 | 312.50 | 61.21 | 2538.00 | 2223.00 | 1.1417 | 1.0518 |
SK-BR-3 | Erlotinib | 10 | uM | 8 | 1250.00 | 894.42 | 1216.00 | 2319.50 | 0.5243 | 0.2503 |
SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 1250.00 | 894.42 | 2467.00 | 2319.50 | 1.0636 | 1.0917 |
MCF 10A | Erlotinib | 10 | uM | 9 | 625.00 | 186.95 | 288.00 | 2801.00 | 0.1028 | 0.1170 |
MCF 10A | Erlotinib | 0.1 | uM | 9 | 625.00 | 186.95 | 2582.00 | 2801.00 | 0.9218 | 0.9587 |
MCF 10A | Erlotinib | 0.01 | uM | 7 | 312.50 | 61.21 | 2226.00 | 2223.00 | 1.0013 | 1.0005 |
MCF 10A | Erlotinib | 0.0033113 | uM | 7 | 312.50 | 61.21 | 2328.00 | 2223.00 | 1.0472 | 1.0179 |
SK-BR-3 | Erlotinib | 19.9526 | uM | 8 | 1250.00 | 894.42 | 1209.00 | 2319.50 | 0.5212 | 0.2451 |
MCF 10A | Erlotinib | 10 | uM | 7 | 312.50 | 61.21 | 195.00 | 2223.00 | 0.0877 | 0.2505 |